CORC

在结果中检索

CORC

浏览/检索结果: 共11条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：17/0  |  提交时间：2022/12/22
Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY) 会议论文
作者:  Zhou, J.;  Eng-Wong, J.;  Mao, Y.;  Althaus, B.;  Liao, N.
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Liu, Tianshu;  Qin, Yanru;  Li, Jin;  Xu, Ruihua;  Xu, Jianming
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
Pertuzumab (P) as >= second-line therapy for HER2-positive metastatic breast cancer (mBC): Swiss clinical experience 期刊论文
ANNALS OF ONCOLOGY, 2019, 卷号: 30
作者:  Biskup, E. M.;  Sartorius, C. Montavon;  Mueller, A.;  Leo, C.;  Nussbaum, C. Uhlmann
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/06
Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer 期刊论文
2019, 卷号: 30, 期号: 8, 页码: 866-872
作者:  Luo Yang;  Li Wei;  Jiang Zefei;  Zhang Qingyuan;  Wang Liwei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Pertuzumab联合trastuzumab和化疗一线治疗转移性HER2~+胃或胃食管交界癌(JACOB)研究解读 期刊论文
中国癌症杂志, 2018, 卷号: 28, 期号: 11
作者:  周昌明;  储黎;  石燕
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Population Pharmacokinetic and Covariate Analysis of Apatinib, an Oral Tyrosine Kinase Inhibitor, in Healthy Volunteers and Patients with Solid Tumors 期刊论文
CLINICAL PHARMACOKINETICS, 2017, 卷号: 56, 期号: 1, 页码: 65-76
作者:  Yu, Mingming;  Gao, Zhiwei;  Dai, Xiaojian;  Gong, Hui;  Zhang, Lianshan
收藏  |  浏览/下载：19/0  |  提交时间：2019/01/08
HER2-targeted antibody drug conjugates for ovarian cancer therapy 期刊论文
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 卷号: 93, 页码: 274-286
作者:  Jiang, Jing;  Dong, Lihou;  Wang, Lei;  Wang, Ling;  Zhang, Jing
收藏  |  浏览/下载：52/0  |  提交时间：2019/01/08
从美国FDA批准新药看生物制品和化学药在临床审评方面考量的异同——以HER2阳性转移性乳腺癌药品帕妥珠单抗及拉帕替尼为例 期刊论文
中国新药杂志, 2014
董可; 李大蔚; 姚立新; 郑强
收藏  |  浏览/下载：5/0  |  提交时间：2015/11/11
Atomic force microscopy study of the effect of HER 2 antibody on EGF mediated ErbB ligand-receptor interaction 期刊论文
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 卷号: 9, 期号: 5, 页码: 627-635
作者:  Zhang, Xuejie;  Shi, Xiaoli;  Xu, Li;  Yuan, Jinghe;  Fang, Xiaohong
收藏  |  浏览/下载：53/0  |  提交时间：2019/04/09

©版权所有 ©2017 CSpace - Powered by CSpace